Literature DB >> 1536359

Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players.

D Siegel1, N Benowitz, V L Ernster, D G Grady, W W Hauck.   

Abstract

BACKGROUND: The use of smokeless tobacco (ST), which has increased in popularity over the past 2 decades, results in considerable systemic exposure to nicotine. Nicotine might contribute to atherosclerosis by an effect on cardiovascular risk factors.
METHODS: The effects of ST use on cardiovascular risk factors and cotinine and nicotine levels were studied in 1061 professional baseball players during spring training in 1988 and 1989.
RESULTS: Of the study participants 477 (45%) were users. ST use was more common among Whites (55%) than among Blacks (29%) or Hispanics (21%), and users reported heavier consumption of alcohol (p less than .001) and had higher mean serum caffeine levels (p less than .001) than nonusers. ST users did not differ from nonusers in adjusted levels of systolic and diastolic blood pressure, pulse, and total or HDL-cholesterol. Among ST users, participants using snuff had higher mean serum cotinine levels than those who used chewing tobacco (p less than .001). There was no association between serum cotinine levels and adjusted levels of any cardiovascular risk factor studied. However, higher diastolic blood pressures were associated with higher mean serum nicotine levels (p = .02).
CONCLUSIONS: Smokeless tobacco use has at most a modest effect on cardiovascular risk factors in young physically fit men.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536359      PMCID: PMC1694380          DOI: 10.2105/ajph.82.3.417

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  18 in total

1.  Optimum cutoff points for biochemical validation of smoking status.

Authors:  S R Cummings; R J Richard
Journal:  Am J Public Health       Date:  1988-05       Impact factor: 9.308

2.  Use of smokeless tobacco, cigarette smoking, and hypercholesterolemia.

Authors:  L A Tucker
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

3.  Smokeless is not saltless.

Authors:  N B Hampson
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

4.  Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids.

Authors:  P Jacob; M Wilson; N L Benowitz
Journal:  J Chromatogr       Date:  1981-01-02

5.  Smokeless tobacco use and health effects among baseball players.

Authors:  V L Ernster; D G Grady; J C Greene; M Walsh; P Robertson; T E Daniels; N Benowitz; D Siegel; B Gerbert; W W Hauck
Journal:  JAMA       Date:  1990-07-11       Impact factor: 56.272

6.  Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users.

Authors:  E R Gritz; V Baer-Weiss; N L Benowitz; H Van Vunakis; M E Jarvik
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Snuff dipping and oral cancer among women in the southern United States.

Authors:  D M Winn; W J Blot; C M Shy; L W Pickle; A Toledo; J F Fraumeni
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

8.  Hemodynamic effects of oral smokeless tobacco in dogs and young adults.

Authors:  W G Squires; T A Brandon; S Zinkgraf; D Bonds; G H Hartung; T Murray; A S Jackson; R R Miller
Journal:  Prev Med       Date:  1984-03       Impact factor: 4.018

9.  Daily use of smokeless tobacco: systemic effects.

Authors:  N L Benowitz; P Jacob; L Yu
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

10.  Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum.

Authors:  N L Benowitz; H Porchet; L Sheiner; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

View more
  16 in total

1.  Spit (smokeless) tobacco use by high school baseball athletes in California.

Authors:  M M Walsh; J Ellison; J F Hilton; M Chesney; V L Ernster
Journal:  Tob Control       Date:  2000       Impact factor: 7.552

2.  Factors associated with smokeless tobacco cessation in an Appalachian population.

Authors:  Ross M Kauffman; Amy K Ferketich; Alvin G Wee; Jennifer M Shultz; Patty Kuun; Mary Ellen Wewers
Journal:  Addict Behav       Date:  2008-01-11       Impact factor: 3.913

Review 3.  Smokeless tobacco and cardiovascular disease in low and middle income countries.

Authors:  Rajeev Gupta; Nishant Gupta; R S Khedar
Journal:  Indian Heart J       Date:  2013-07-16

4.  Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers.

Authors:  G Bolinder; L Alfredsson; A Englund; U de Faire
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

5.  Effect of nicotine on lipoprotein metabolism in rats.

Authors:  L Ashakumary; P L Vijayammal
Journal:  Lipids       Date:  1997-03       Impact factor: 1.880

6.  In vitro effect of nicotine and cotinine on the susceptibility of LDL oxidation and hemoglobin glycosylation.

Authors:  S Asgary; G H Naderi; N Sarrafzadegan; M Gharypur
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

7.  Knowledge, intent to use, and use of smokeless tobacco among sixth grade schoolchildren in six selected U.S. sites.

Authors:  C L Backinger; B Bruerd; M B Kinney; S M Szpunar
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

8.  Spit (Smokeless)-Tobacco Use by Baseball Players Entering the Professional Ranks.

Authors:  Jeff Cooper; James A. Ellison; Margaret M. Walsh
Journal:  J Athl Train       Date:  2003-06       Impact factor: 2.860

9.  Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India.

Authors:  Ambarish Pandey; Nivedita Patni; Sasmit Sarangi; Mansher Singh; Kartavya Sharma; Ananth K Vellimana; Somdutta Patra
Journal:  Tob Induc Dis       Date:  2009-11-24       Impact factor: 2.600

10.  Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parameters.

Authors:  Aytekin Guven; Fatma Tolun
Journal:  Int J Med Sci       Date:  2012-10-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.